UBQLN2 and amyotrophic lateral sclerosis: While we acknowledge that a direct side-by-side comparison of all mouse models using the same proteomics platform with appropriate batch controls is required to unambiguously identify unique and shared features across these model – our re-analysis of previously published data indicates that young Ubqln2 KO mice recapitulate the top features identified in late-stage ALS in humans.